Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [74]
News [51]
Articles [25]
Editorials [8]
Conferences [0]
elearning [0]
Biomarker guidance allows patients 55 or older with low-grade luminal A-type...
Dr Timothy J. Whelan - McMaster University, Ontario, Canada
Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy ( Dr Timothy J. Whelan - McMaster University, Ontario, Canada )
9 Jun 2022
Comment: Biomarker guidance allows patients 55 or older with low-grade luminal...
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Comment: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
7 Jun 2022
Luminal A-type breast cancer patients with low levels of the Ki67 biomarker can...
Dr Timothy J. Whelan - McMaster University, Ontario, Canada
Luminal A-type breast cancer patients with low levels of the Ki67 biomarker can avoid outcomes related to radiotherapy ( Dr Timothy J. Whelan - McMaster University, Ontario, Canada )
7 Jun 2022
ASCO 2022: Highlights and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ASCO 2022: Highlights and analysis ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
6 Jun 2022
The global impact of the FDA's changing approval standards
Dr Bishal Gyawali - Queen's University, Kingston, Canada
The global impact of the FDA's changing approval standards ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
2 Feb 2022
Evidence-based oncology for trainees from LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Evidence-based oncology for trainees from LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
14 Jan 2022
Cancer drug policy and access in LMICs
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Cancer drug policy and access in LMICs ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
26 Nov 2021
Choosing Trials Wisely: What type of clinical trials should be a priority for...
Dr Bishal Gyawali - Queen's University, Kingston, Canada and Department of...
Choosing Trials Wisely: What type of clinical trials should be a priority for LMICs? ( Dr Bishal Gyawali - Queen's University, Kingston, Canada and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA )
6 Oct 2021
ESMO 2021 Roundup
Dr Bishal Gyawali - Queen's University, Kingston, Canada
ESMO 2021 Roundup ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
22 Sep 2021
Highlights from ASCO 2021
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Highlights from ASCO 2021 ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
8 Jun 2021
Communication in oncology: Does it matter?
Dr Bishal Gyawali - Queen's University, Kingston, Canada and Department of...
Communication in oncology: Does it matter? ( Dr Bishal Gyawali - Queen's University, Kingston, Canada and Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA )
11 Apr 2021
Why overall survival is still the gold standard end point
Dr Bishal Gyawali - Queen's University, Kingston, Canada
Why overall survival is still the gold standard end point ( Dr Bishal Gyawali - Queen's University, Kingston, Canada )
13 Jan 2021

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation